6results about How to "Lower triglycerides" patented technology

The invention provides a probiotics plant solid beverage for treating hyperuricemia and gout. The solid beverage is prepared by mixing freeze-dried probiotics powder and plant extract with the addition of proper auxiliary materials. The solid beverage comprises the following components: the plant extract, the auxiliary materials and the probiotics, with the sum of the mass percentage of each component being 100%. The plant extract comprises celery seed powder, sophora flower bud powder and platycodon root powder. The invention has an obvious effect on lowering uric acid and relieving gout.

This invention discloses an oil composition with a balanced fatty acid ratio and lipid-lowering effects, and its applications. The oil composition comprises vegetable oil, probiotics, phospholipids from camellia seed cake, gelatin, and sodium alginate. It effectively reduces serum triglyceride, total cholesterol, and low-density lipoprotein cholesterol levels while increasing high-density lipoprotein cholesterol levels, exhibiting a good lipid-lowering effect. Furthermore, when the oil composition is formulated into microcapsules, it exhibits good stability, encapsulation efficiency, and release rate. The oil composition also helps maintain the activity of probiotics, allowing for better preservation and efficacy. Based on this, this invention also provides a candy containing the oil composition, enriching the variety of products with lipid-lowering effects and promoting the development of lipid-lowering related products.

The invention discloses mushroom and lucid ganoderma wine and a brewing method thereof.The mushroom and lucid ganoderma wine is prepared from 260-300 kg of rice wine, 430-470 kg of distilled liquor, 6-12 kg of mushrooms, 1-5 kg of lucid ganoderma, 2-7 kg of milkvetch roots, 2-7 kg of Chinese wolfberry fruits, 1-5 kg of mulberries, 6-12 kg of cistanche deserticola and 250-300 kg of cold boiled water according to 1000 kg of finished products. The lentinus edodes and lucid ganoderma wine brewed by the method integrates the effects of various medicinal and edible food materials such as the sticky rice, the lentinus edodes, the lucid ganoderma and the astragalus membranaceus, and has relatively high nutritional and medicinal values; the effects of resisting cancer, enhancing human immunity, tonifying qi, soothing the nerves, relieving cough and asthma, supporting healthy energy, protecting the liver, resisting fatigue, delaying senescence, reducing blood sugar, promoting circulation, expanding blood vessels, reducing blood cholesterol and triglyceride and the like can be achieved.

The present application relates to a kind of feed additive for improving fatty liver of post- laying hen and its preparation method and application method, belong to livestock and poultry feed processing technical field.For the single component additive effect of post- laying hen fatty liver is limited, and lack of the plant combination with synergistic effect screened from local characteristic plant resources.The feed additive provided by the present application comprises the ethanol extract of the mixture of small Xianggou root, tea leaf piece and San Ye Qing tuber, and the weight ratio of small Xianggou root, tea leaf piece and San Ye Qing tuber is (4.0-4.2) : (3.3-3.4) : 2.6.The additive can systematically improve the liver lipid metabolism of post- laying hen, reduce the triglyceride and total cholesterol levels in liver and serum, relieve fatty liver hemorrhagic syndrome, and improve egg production rate and egg quality.The additive is mainly used for post- laying hen feed to improve liver health and maintain production performance.

The invention provides application of typhaenoside and / or an active metabolite thereof in preparation of a medicine for preventing and / or treating hyperlipidemia, and belongs to the technical field of medicines. The invention also provides application of the cattail new glycoside and / or active metabolites thereof and pharmaceutically acceptable salts, hydrates, solvates, enantiomers, stereoisomers and tautomers thereof in preparation of drugs for prevention and / or treatment of hyperlipidemia, wherein the active metabolites and the pharmaceutically acceptable salts, hydrates, solvates, enantiomers, stereoisomers and tautomers of the cattail new glycoside are provided. The cattail new glycoside or the active metabolite of the cattail new glycoside can obviously reduce the levels of triglyceride, total cholesterol, low-density lipoprotein cholesterol and fasting blood-glucose in blood of an ob / ob hyperlipemia mouse, and meanwhile, the hypertrophy of adipocytes in epididymis white adipose tissues caused by hyperlipemia is obviously improved. As a medicine for reducing blood fat and treating hyperlipidemia, the typha orientalis glucoside or the active metabolite of the typha orientalis glucoside has a huge market application prospect.

The application provides an effect and application of CREPT in fatty liver disease and complications thereof, in particular, application of CREPT gene or protein as a target or a reagent for targeting the CREPT gene or protein in treatment of metabolic-related fatty liver disease and fatty liver disease complications or in preparation of a medicine for treating metabolic-related fatty liver disease and fatty liver disease complications, and the metabolic-related fatty liver disease and fatty liver disease complications are treated by reducing the expression of the CREPT gene or reducing the function or inactivating the CREPT protein. The present application firstly finds that the CREPT is closely related to the metabolic-related fatty liver disease: the systemic or local medication can effectively treat the metabolic-related fatty liver disease and fatty liver disease complications by reducing the expression of the CREPT.